FOR PROFESSIONAL INVESTORS ONLY

Lever VC

Sector-specialist fund focused entirely on alternative protein
Principal Partners have proven track record investing in over 60 alternative protein deals, with stellar returns and exits
Global coverage of sector with exceptional deal flow and on-the- ground presence in the U.S., U.K., France, Israel, India, Hong Kong, mainland China, and Singapore

LEVER VC: PROVEN SECTOR EXPERTS INVESTING IN THE FUTURE OF PROTEIN

152%

Gross IRR

2.5x

Multiple on Invested Capital

50 Million

Target Fund Size

Fund Type

Growth

Geographies

International

Industry Focus

Animal proteins
Fund Lifetime
7+1+1 years

Status of Fundraising

42 Million Closed

Closing Date

June 2021

Track Records

As part of Venture Smart’s rigorous selection and due diligence process, we analyse the fund’s investment record for the specific fund strategy in great detail. We scrutinize investment level performance, comparing investment strategy with results and understanding the team’s actions to drive overperformance and manage under performance.

For definitions of investment terms and metrics please review our glossary.

Why Lever VC

Venture Smart, including its management and advisors, only offers investments that have gone through a rigorous due diligence process once we are convinced of the merits of the investment opportunity. 

For definitions of investment terms and metrics please review our glossary.

Global need for alternative proteins

Owing to supply constraints in the animal proteins industry, alternative proteins will make up one-third of the global protein market by mid-century, with sales of plant-based meat alone reaching an estimated US$140 billion by 2029.

Secular shift in consumer preferences

Consumer considerations of health, sustainability and animal welfare are driving the shift toward alternative proteins. Interest is particularly strong among Gen-Z and millennial consumers, who are set to have the highest spending power over the next decade.

Increasing pace of investment and acquisition

Leading investment firms and major food companies have invested more than US$4 billion in alternative protein startups in the past five years. The pace of acquisitions is also continually increasing, providing ample opportunity for liquidity events.

Unparalleled track record

Investment team has collectively made 60+ alternative protein investments; partners Nick Cooney and Lawrence Chu have a track record of 8.6x TVPI and 86% IRR, and 6.5x TVPI and 69% IRR, respectively.

Proven performance; limited blind pool risk

Since initial deployment in July 2019, the fund has made 14 investments and achieved a Multiple on Invested Capital of 2.5x and an IRR of 152%. A third closing at ~US$47 million will be completed in March 2021.

Terms & Legal

Lever VC

Fund Manager

Venture Smart Financial Group

Investment Manager

Lever VC

Carry and Management Fee

20% / 2.5%
Setup fee(one-time) for GP

Not Applicable

Tax status

TBC

Other Charges

Not Applicable

Remarks

Venture Smart Financial Group, a Type 1,4,9 SFC-licensed asset manager owned by Lawrence Chu;

留下您的联络资料以了解更多

  •  
免责声明

警告声明

过往表现并不代表未来表现。 由于货币波动,回报可能会增加或减少。 所有业绩数据均按资产净值计算,并扣除费用及再投资的股利,并且不考虑发行和赎回单位时产生的佣金和成本。 以美元/港元为基础的投资者在投资以美元/港元以外的货币计价的产品时,将面临货币波动的风险。

如果某股份类别的成立时间少于12个日历月,则无法提供表现数据。 但是,如果该股票类别的成立时间超过12个日历月,则会在基金资讯文件中提供同一基金的其他股票类别的表现数据。 由于对冲策略和费用等因素,股票类别之间的表现可能有所不同。

重要信息

  • 该投资涉及可能导致部分或全部投资损失的风险。
  • 投资者不应仅依靠本文件做出任何投资决定。 您应阅读并理解发行文件,以了解包括风险因素在内的更多基金细节。
logo_only

意博金融致力为客户提供个人化资产管理方案,把握环球投资机遇。

联络我们

总部及主要营业地点

香港铜锣湾希慎道18号利园五期23楼

铜锣湾办公室

香港铜锣湾新宁道8号中国太平大厦二期12楼